reference/33502984

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33502984

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	2337
issn	0008-5472 1538-7445
issueIdentifier	7
pageRange	2333-2337
publicationName	Cancer Research
startingPage	2333
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_af724476d1bf3269a271064122c1aef6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e33bb78372b23fc74dac422ba1d2aa09 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc9e9760bcb42432aa5dc2cc8d92b0a0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc796d105798b72fe6eafaa040510461
bibliographicCitation	Houghton PJ, Germain GS, Harwood FC, Schuetz JD, Stewart CF, Buchdunger E, Traxler P. Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Cancer Res. 2004 Apr 01;64(7):2333–7. doi: 10.1158/0008-5472.can-03-3344. PMID: 15059881.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e83b80113cc6375c23531acf8a6b586c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f514bb40b583e2dc4d935f3fc08a164 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2760c580dac4dc981adab64fea9ba15 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0eed673030645e23613947f5baf70e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_383c7a124a0cf6d2caefdd6d78493364 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f531ada03cd9ad6da73a45ae3589662b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86783e6069247db192d23389e4d8ccd3
date	2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15059881 https://doi.org/10.1158/0008-5472.can-03-3344
isPartOf	https://portal.issn.org/resource/ISSN/1538-7445 https://portal.issn.org/resource/ISSN/0008-5472 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro
discusses	http://id.nlm.nih.gov/mesh/M0027776 http://id.nlm.nih.gov/mesh/M000612844 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0147530 http://id.nlm.nih.gov/mesh/M0003242 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0299734 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0029340 http://id.nlm.nih.gov/mesh/M0014578
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009363Q000037 http://id.nlm.nih.gov/mesh/D019772Q000494 http://id.nlm.nih.gov/mesh/D010879Q000494 http://id.nlm.nih.gov/mesh/D018528Q000037 http://id.nlm.nih.gov/mesh/D011743Q000494 http://id.nlm.nih.gov/mesh/D002166Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019772Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012516Q000378 http://id.nlm.nih.gov/mesh/D012516Q000188 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D002166Q000031 http://id.nlm.nih.gov/mesh/D000077146 http://id.nlm.nih.gov/mesh/D001859Q000378 http://id.nlm.nih.gov/mesh/D000070997 http://id.nlm.nih.gov/mesh/D004791Q000494 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D001859Q000188 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11643997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104842 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1e4d7f806ea44eba476b32d2ebb4249 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5bf20507b757dd624886dac9baef5c7d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID324081 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217

Incoming Links

Predicate	Subject
citesAsDataSource	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103619406_AID682137_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103170619_AID679628_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103220117_AID679628_VALUE2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520161 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9429 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129687246 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347572 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128646509 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127400640

Predicate

Subject

citesAsDataSource

http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103619406_AID682137_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103170619_AID679628_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103220117_AID679628_VALUE2

isDiscussedBy

Total number of triples: 90.